Adverse drug reactions and laboratory abnormalities reported in patients with ≥ 5 events (n = 1,293).</p
Adverse events (according to low-level term) reported in at least 10 patients during follow-up.</p
The annual cost of drug-related morbidity and mortalityin the US has been estimated1 at more than $1...
The rapidly expanding discipline of pharmacogenetics has helped to explain the mechanisms of suscept...
<p>Serious adverse events in patients who completed all pharmacokinetic assessments (N = 25) and in ...
Drug-related problems, including adverse drug reactions (ADRs), contribute to a significant health- ...
This study investigated the occurrence and characteristics of adverse drug reactions (ADR) in our ho...
<p>*Listing includes all events occurring in >1 patient.</p>†<p>No single event occurred in >3 patie...
<p>N, number of patients; n, number of events; %, percentage based on N = 275.</p
<p>Most common treatment-related adverse events reported in ≥10% of patients.</p
<p>Occurrence of adverse events in patients grouped by ITPase activity, percentage of adverse events...
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
Adverse reactions noted in the study which were not related to the trial drug.</p
<p>Treatment-emergent adverse events experienced by ≥3 patients in any treatment group in the Phase ...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
An organized Adverse Drug Reaction monitoring program is one mechanism to more actively detect ADRs,...
Adverse events (according to low-level term) reported in at least 10 patients during follow-up.</p
The annual cost of drug-related morbidity and mortalityin the US has been estimated1 at more than $1...
The rapidly expanding discipline of pharmacogenetics has helped to explain the mechanisms of suscept...
<p>Serious adverse events in patients who completed all pharmacokinetic assessments (N = 25) and in ...
Drug-related problems, including adverse drug reactions (ADRs), contribute to a significant health- ...
This study investigated the occurrence and characteristics of adverse drug reactions (ADR) in our ho...
<p>*Listing includes all events occurring in >1 patient.</p>†<p>No single event occurred in >3 patie...
<p>N, number of patients; n, number of events; %, percentage based on N = 275.</p
<p>Most common treatment-related adverse events reported in ≥10% of patients.</p
<p>Occurrence of adverse events in patients grouped by ITPase activity, percentage of adverse events...
Treatment-related adverse events occurring in ≥1% of the total population (SS).</p
Adverse reactions noted in the study which were not related to the trial drug.</p
<p>Treatment-emergent adverse events experienced by ≥3 patients in any treatment group in the Phase ...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
An organized Adverse Drug Reaction monitoring program is one mechanism to more actively detect ADRs,...
Adverse events (according to low-level term) reported in at least 10 patients during follow-up.</p
The annual cost of drug-related morbidity and mortalityin the US has been estimated1 at more than $1...
The rapidly expanding discipline of pharmacogenetics has helped to explain the mechanisms of suscept...
DOI
Add to ORKG